Health Insight
Advocacy
-
What You Can Do to Support a Grieving Child in Canada
Not only do children grieve the loss of a loved one, but that same loss can also affect their cognitive and emotional development.
-
Research and Development Are Crucial to Discoveries in Rare Disease
Susi Vander Wyk explains how R&D could help increase access to treatment for Canadians living with spinal muscular atrophy.
-
Take Your Joint Pain Seriously
Osteoarthritis is a progressive disease that leads to the breakdown of joint cartilage and the underlying bone.
-
Knee Health: Helping Curb the Osteoarthritis Epidemic in Canada
The Stop OsteoARthritis program aims to help people with a prior knee injury to reduce their risk of developing osteoarthritis.
-
Virtual Health Care Evolving to Ensure Patient Needs Are Priority
CAPA has been involved with the Canadian Rheumatology Association in the development of best-practice statements for virtual health care.
-
How Young Is Too Young to Be High Risk for COVID-19
During the pandemic, it was highlighted that those with autoimmune conditions like rheumatoid arthritis are at high risk for COVID-19.
-
Maayan Ziv: How to Be Your Own Health Care Advocate
As the founder of AccessNow, Maayan Ziv is a leader in the junction of healthcare and technology. Mediaplanet spoke with Ziv on the importance of being your own advocate and the future of health and accessibility. Why did you decide to start AccessNow? Maayan Ziv: AccessNow started because of my experiences as a person with...
-
s Sponsored
How the CMPNRF and the CMPNN Are Meeting the Needs of the MPN Community
There are many types of blood cancers that aren’t as well-known. For those living with myeloproliferative neoplasms (MPNs), these serious cancers are very real.
-
s Sponsored
Making Myeloma Matter
Myeloma is the 2nd most common form of blood cancer. Nine new Canadians are diagnosed with myeloma every day, yet we are without a cure.
-
Not All Rare Blood Disorders Are Treated Alike
All Canadians with rare blood disorders should have the same access to the best treatment. That's the vision for the national Rare Disease Drug Strategy.